Status:
COMPLETED
Clearance of Nasal Staphylococcus Aureus With Triple Antibiotic Ointment
Lead Sponsor:
Northwestern University
Conditions:
Nasal Carriers of Staphylococcus Aureus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Staphylococcus aureus, a bacteria that lives commonly in the anterior nostrils, is seen in about 30% of healthcare workers. Applying mupirocin ointment, a prescription, to the nostrils twice daily for...
Eligibility Criteria
Inclusion
- Willing and able to give informed consent
- Must have consented prior to registration for the study
Exclusion
- active infection
- concurrent treatment with antibiotics, topical or systemic
- S. aureus decolonization attempt in prior six months
- history of HIV
- chemotherapy or systemic immunosuppressive therapy
- history of neomycin allergy or sensitivity
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
216 Patients enrolled
Trial Details
Trial ID
NCT00997139
Start Date
September 1 2009
End Date
November 1 2010
Last Update
January 5 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University
Chicago, Illinois, United States, 60611